Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits

被引:6
作者
Nielsen, EMD
Hansen, L
Stissing, T
Yanagisawa, K
Borch-Johnsen, K
Poulsen, P
Vaag, A
Hansen, T
Pedersen, O
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Hagedorn Res Inst, Copenhagen, Denmark
[3] Novo Nordisk AS, Sci & Med, DK-2880 Bagsvaerd, Denmark
[4] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark
[5] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2005年 / 83卷 / 05期
关键词
CDKN1C; CDK4; mutation analysis; polymorphisms; birth weight; type; 2; diabetes;
D O I
10.1007/s00109-005-0647-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
CDK4 is involved in the regulation of body weight, pancreatic beta-cell proliferation, insulin responsiveness, and diabetes pathogenesis. CDK4 activity is inhibited by CDKN1C, which is regulated by insulin. In addition, CDKN1C plays an important role in beta-cell proliferation and is involved in the pathogenesis of the Beckwith-Wiedemann syndrome, a disorder characterized by neonatal hyperinsulinaemic hypoglycaemia and pre- and post-natal overgrowth. The aim of this study was to investigate if variations in the proximal promoter and the coding region of the CDKN1C and CDK4 genes are associated with type 2 diabetes or changes in related quantitative phenotypes among glucose-tolerant subjects. Mutation analyses of the two genes in 62 type 2 diabetic patients resulted in the discovery of seven variants of CDKN1C and two variants of CDK4. In a case-control study comprising 717 type 2 diabetic patients and 518 glucose-tolerant subjects the most frequent variants did not show any difference in allele frequencies between the type 2 diabetic patients and the control subjects. However, in two genotype-quantitative trait correlation studies involving 206 glucose-tolerant offspring of type 2 diabetic patients and 359 young, healthy subjects the CDKN1C del171APVA variant associated with increased birth weight (P=0.05 and P=0.05). Furthermore, the same variant tended to be associated with decreased basal glucose oxidation among 16 genotypically discordant dizygotic twins (P=0.03). In a genotype-quantitative trait study involving 500 middle-aged glucose-tolerant subjects the CDK4 IVS2-31G -> A variant was associated with an increased waist circumference (P=0.03) and waist-to-hip ratio (P=0.02) and altered fasting plasma glucose (P=0.03). However, these later findings could not be replicated in additional studies. In conclusion, variants in CDKN1C may contribute to the inter-individual variation in birth weight.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 39 条
[1]   Impact of hemodialysis on dual X-ray absorptiometry, bioelectrical impedance measurements, and anthropometry [J].
Abrahamsen, B ;
Hansen, TB ;
Hogsberg, IM ;
Pedersen, FB ;
BeckNielsen, H .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (01) :80-86
[2]   Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies [J].
Ahrén, B ;
Pacini, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (02) :97-104
[3]   EQUIVALENCE OF THE INSULIN SENSITIVITY INDEX IN MAN DERIVED BY THE MINIMAL MODEL METHOD AND THE EUGLYCEMIC GLUCOSE CLAMP [J].
BERGMAN, RN ;
PRAGER, R ;
VOLUND, A ;
OLEFSKY, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :790-800
[4]   Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians - Analysis of the impact of gender, body fat, physical fitness, and life-style factors [J].
Clausen, JO ;
BorchJohnsen, K ;
Ibsen, H ;
Bergman, RN ;
Hougaard, P ;
Winther, K ;
Pedersen, O .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) :1195-1209
[5]   Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes [J].
Drivsholm, T ;
Ibsen, H ;
Schroll, M ;
Davidsen, M ;
Borch-Johnsen, K .
DIABETIC MEDICINE, 2001, 18 (02) :126-132
[6]   BECKWITH-WIEDEMANN SYNDROME [J].
ELLIOTT, M ;
MAHER, ER .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (07) :560-564
[7]  
Gaston V, 2000, HORM RES, V54, P1
[8]   Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes [J].
Hansen, L ;
Gaster, M ;
Oakeley, EJ ;
Brusgaard, K ;
Nielsen, EMD ;
Beck-Nielsen, H ;
Pedersen, O ;
Hemmings, BA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 323 (02) :685-695
[9]   Identification of a common amino acid polymorphism in the p85 alpha regulatory subunit of phosphatidylinositol 3-kinase - Effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index [J].
Hansen, T ;
Andersen, CB ;
Echwald, SM ;
Urhammer, SA ;
Clausen, JO ;
Vestergaard, H ;
Owens, D ;
Hansen, L ;
Pedersen, O .
DIABETES, 1997, 46 (03) :494-501
[10]   An imprinted gene p57(KIP2) is mutated in Beckwith-Wiedemann syndrome [J].
Hatada, I ;
Ohashi, H ;
Fukushima, Y ;
Kaneko, Y ;
Inoue, M ;
Komoto, Y ;
Okada, A ;
Ohishi, S ;
Nabetani, A ;
Morisaki, H ;
Nakayama, M ;
Niikawa, N ;
Mukai, T .
NATURE GENETICS, 1996, 14 (02) :171-173